Global Med Technologies Signs Binding Letter of Intent to Acquire Hemo-Net(R)

DENVER, Oct. 6 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (“Global Med” or the “Company”) , an international healthcare information technology company, today announced that it has signed a binding letter of intent with Denver-based Bonfils Blood Center to acquire Hemo-Net(R). A subsidiary of the blood center, Hemo-Net is a pioneering application service provider (ASP) specializing in the medical technology field. Hemo-Net is based in Denver, Colorado. Hemo-Net currently hosts business solutions for Global Med’s customers in the United States and Africa. Hemo-Net’s revenues in the next calendar year will be approximately $900,000, with an expected positive EBIDTA. The acquisition is expected to close by November 1, 2009. Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

Created in 2003, Hemo-Net provides secure, highly-available and cost-effective software hosting applications with a strong understanding of its impact on the success of healthcare organizations. Hemo-Net is responsible for the maintenance and availability of mission critical applications and the security of the machines that serve those applications. Data is secured in multiple locations so that it maintains its integrity, especially in the event of natural or man-made disasters. Hosting is also an excellent solution for providing advanced healthcare systems to areas in the world where scarce resources prevent most modern systems from being implemented. Hemo-Net’s ASP service provides a secure and cost-effective method for blood centers and hospitals to purchase systems or upgrade their current software to state-of-the-art systems without incurring the costs associated with purchasing and maintaining their own equipment.

Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc., commented, “The acquisition of Hemo-Net is expected to complement Global Med’s strong line of international blood management and laboratory information software and service solutions by offering alternative hosting methods. We have seen first hand the invaluable nature of offering our customers a hosted solution. In fact, Hemo-Net was indispensable in assisting our customer, The Blood Center of New Orleans, to quickly resume operations after Hurricane Katrina in 2005. From its Denver headquarters, Hemo-Net was able to remotely restore The Blood Center’s critical IT functions.”

Dr. Ruxin continued, “We understand the industry’s need for advanced healthcare solutions and the monetary constraints placed on healthcare organizations in today’s economy. Global Med’s acquisition of Hemo-Net is a vital piece of the Company’s overall corporate strategy to provide comprehensive and flexible business solutions to our customers.”

Thomas C. Puckett, President and Chief Executive Officer of Bonfils Blood Center, stated, “We are very pleased that our long-time vendor and trusted partner, Global Med Technologies, will be taking ownership of Hemo-Net. We have the utmost confidence that Global Med will continue to provide outstanding service for Bonfils and our existing blood center clients. We also believe that Global Med is uniquely positioned to grow the business and bring ASP services to healthcare centers around the world.”

About Bonfils Blood Center

For more than 65 years, the Colorado-based Bonfils Blood Center has successfully managed the community blood supply and played an integral role in Colorado’s healthcare system. Bonfils Blood Center supplies blood to nearly 200 healthcare facilities across the state and beyond and needs to collect more than 3,300 blood donations each week to meet the needs of the community and to be prepared for any unexpected events. For information about Bonfils Blood Center please call 800.365.0006 or visit www.bonfils.org.

About Global Med Technologies(R), Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med’s products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med’s domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med’s European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med’s products and services, please call 800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.

CONTACT: company, Michael I. Ruxin, M.D. of Global Med Technologies, Inc.,
+1-303-238-2000, or investors, Jeffrey Benison, +1-212-334-8709,
jeffrey@littlegem.us; or Blood Center, Bonfils Blood Center, Julie Scott,
PR Specialist, +1-303-361-2873, Julie_Scott@bonfils.org

Web site: http://www.globalmedtech.com/
http://www.bonfils.org//

MORE ON THIS TOPIC